| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | cell-cell adhesion | CHL1 CNTN4 FLOT2 CLSTN3 ITCH ANK3 KRT18 PCDHGB5 HLA-DRB1 HLA-DRB4 HLA-DRB5 ITGAM GLI2 DCHS1 ELANE ANXA9 PCDHB1 PCDHGC3 TNXB CDH11 | 6.46e-06 | 1077 | 124 | 20 | GO:0098609 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 1.77e-05 | 187 | 124 | 8 | GO:0007156 | |
| GeneOntologyBiologicalProcess | cochlea development | 3.29e-05 | 61 | 124 | 5 | GO:0090102 | |
| GeneOntologyBiologicalProcess | ultradian rhythm | 3.59e-05 | 2 | 124 | 2 | GO:0007624 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in membrane | 1.07e-04 | 3 | 124 | 2 | GO:0072658 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in plasma membrane | 1.07e-04 | 3 | 124 | 2 | GO:0072660 | |
| GeneOntologyBiologicalProcess | MHC class II protein complex assembly | 1.12e-04 | 16 | 124 | 3 | GO:0002399 | |
| GeneOntologyBiologicalProcess | peptide antigen assembly with MHC class II protein complex | 1.12e-04 | 16 | 124 | 3 | GO:0002503 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 1.17e-04 | 313 | 124 | 9 | GO:0098742 | |
| GeneOntologyCellularComponent | lysosomal membrane | GPLD1 COL6A1 HLA-DRB1 HLA-DRB4 HLA-DRB5 ABCB6 B4GALT1 PLAAT3 UBA1 WDR11 LRP1 | 9.80e-05 | 462 | 124 | 11 | GO:0005765 |
| GeneOntologyCellularComponent | lytic vacuole membrane | GPLD1 COL6A1 HLA-DRB1 HLA-DRB4 HLA-DRB5 ABCB6 B4GALT1 PLAAT3 UBA1 WDR11 LRP1 | 9.80e-05 | 462 | 124 | 11 | GO:0098852 |
| GeneOntologyCellularComponent | collagen type VI trimer | 1.04e-04 | 3 | 124 | 2 | GO:0005589 | |
| GeneOntologyCellularComponent | collagen beaded filament | 1.04e-04 | 3 | 124 | 2 | GO:0098647 | |
| GeneOntologyCellularComponent | MHC class II protein complex | 1.30e-04 | 17 | 124 | 3 | GO:0042613 | |
| GeneOntologyCellularComponent | cell-cell junction | FLOT2 XIRP1 ANK3 KRT18 B4GALT1 ABCB1 VANGL2 LSR UBA1 PCDHGC3 PDLIM2 CDH11 | 2.09e-04 | 591 | 124 | 12 | GO:0005911 |
| GeneOntologyCellularComponent | anchoring junction | FLOT2 XIRP1 ANK3 KRT18 GRB7 B4GALT1 ABCB1 VANGL2 LSR MISP UBA1 LRP1 FZD2 PCDHGC3 PDLIM2 CDH11 | 2.16e-04 | 976 | 124 | 16 | GO:0070161 |
| GeneOntologyCellularComponent | vacuolar membrane | GPLD1 COL6A1 HLA-DRB1 HLA-DRB4 HLA-DRB5 ABCB6 B4GALT1 PLAAT3 UBA1 WDR11 LRP1 | 2.20e-04 | 507 | 124 | 11 | GO:0005774 |
| GeneOntologyCellularComponent | external side of plasma membrane | ENOX1 KRT18 HLA-DRB1 HLA-DRB5 ITGAM B4GALT1 ABCB1 SCUBE1 LRP1 RORC ENOX2 | 2.69e-04 | 519 | 124 | 11 | GO:0009897 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL5A2 COL6A1 COL6A3 CILP LAMA2 ITIH4 ELANE MMP8 ANXA9 TNXB KNG1 | 3.21e-04 | 530 | 124 | 11 | GO:0062023 |
| GeneOntologyCellularComponent | lysosome | GPLD1 COL6A1 ANK3 HLA-DRB1 HLA-DRB4 HLA-DRB5 ABCB6 B4GALT1 PLAAT3 UBA1 WDR11 SLCO2A1 LRP1 ELANE | 3.27e-04 | 811 | 124 | 14 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | GPLD1 COL6A1 ANK3 HLA-DRB1 HLA-DRB4 HLA-DRB5 ABCB6 B4GALT1 PLAAT3 UBA1 WDR11 SLCO2A1 LRP1 ELANE | 3.27e-04 | 811 | 124 | 14 | GO:0000323 |
| GeneOntologyCellularComponent | vacuole | GPLD1 COL6A1 ANK3 HLA-DRB1 HLA-DRB4 HLA-DRB5 ABCB6 CIT B4GALT1 PLAAT3 UBA1 WDR11 SLCO2A1 LRP1 ELANE | 3.36e-04 | 913 | 124 | 15 | GO:0005773 |
| GeneOntologyCellularComponent | MHC protein complex | 4.79e-04 | 26 | 124 | 3 | GO:0042611 | |
| GeneOntologyCellularComponent | extracellular matrix | GPLD1 COL5A2 COL6A1 COL6A3 CILP LAMA2 ITIH4 ELANE MMP8 ANXA9 TNXB KNG1 | 5.34e-04 | 656 | 124 | 12 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | GPLD1 COL5A2 COL6A1 COL6A3 CILP LAMA2 ITIH4 ELANE MMP8 ANXA9 TNXB KNG1 | 5.49e-04 | 658 | 124 | 12 | GO:0030312 |
| GeneOntologyCellularComponent | desmosome | 5.99e-04 | 28 | 124 | 3 | GO:0030057 | |
| GeneOntologyCellularComponent | cell surface | CLSTN3 ENOX1 ANK3 KRT18 HLA-DRB1 HLA-DRB5 ITGAM B4GALT1 ABCB1 SCUBE1 KCNC1 LRP1 ELANE RORC ANXA9 ENOX2 | 8.87e-04 | 1111 | 124 | 16 | GO:0009986 |
| GeneOntologyCellularComponent | sarcolemma | 9.58e-04 | 190 | 124 | 6 | GO:0042383 | |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 1.16e-03 | 35 | 124 | 3 | GO:0098553 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle membrane | 1.26e-03 | 79 | 124 | 4 | GO:0030669 | |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | PCSK1 SLC66A2 HLA-DRB1 HLA-DRB4 HLA-DRB5 CIT B4GALT1 WDR11 COG5 | 1.32e-03 | 443 | 124 | 9 | GO:0098791 |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 1.68e-03 | 212 | 124 | 6 | GO:0030666 | |
| GeneOntologyCellularComponent | endocytic vesicle | 2.09e-03 | 384 | 124 | 8 | GO:0030139 | |
| GeneOntologyCellularComponent | side of membrane | CNTN4 ENOX1 KRT18 HLA-DRB1 HLA-DRB4 HLA-DRB5 ITGAM B4GALT1 ABCB1 SCUBE1 LRP1 RORC ENOX2 | 2.10e-03 | 875 | 124 | 13 | GO:0098552 |
| GeneOntologyCellularComponent | polyprenyl diphosphate synthase complex | 2.22e-03 | 12 | 124 | 2 | GO:0032476 | |
| GeneOntologyCellularComponent | lipoprotein particle | 2.26e-03 | 44 | 124 | 3 | GO:1990777 | |
| GeneOntologyCellularComponent | plasma lipoprotein particle | 2.26e-03 | 44 | 124 | 3 | GO:0034358 | |
| GeneOntologyCellularComponent | trans-Golgi network | 2.36e-03 | 306 | 124 | 7 | GO:0005802 | |
| GeneOntologyCellularComponent | protein-lipid complex | 2.73e-03 | 47 | 124 | 3 | GO:0032994 | |
| GeneOntologyCellularComponent | lumenal side of membrane | 2.90e-03 | 48 | 124 | 3 | GO:0098576 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 3.02e-03 | 320 | 124 | 7 | GO:0016323 | |
| GeneOntologyCellularComponent | Cul4A-RING E3 ubiquitin ligase complex | 3.03e-03 | 14 | 124 | 2 | GO:0031464 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle | 3.09e-03 | 101 | 124 | 4 | GO:0045334 | |
| GeneOntologyCellularComponent | Golgi membrane | GALNT10 CLSTN3 RHBDF1 HLA-DRB1 HLA-DRB4 HLA-DRB5 ABCB6 B4GALT1 ABCB1 COG5 NOS3 | 3.78e-03 | 721 | 124 | 11 | GO:0000139 |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 4.20e-03 | 110 | 124 | 4 | GO:0030134 | |
| GeneOntologyCellularComponent | trans-Golgi network membrane | 4.47e-03 | 112 | 124 | 4 | GO:0032588 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 4.48e-03 | 17 | 124 | 2 | GO:0098637 | |
| HumanPheno | Abnormality of the elbow | CUL4B RAF1 COL5A2 COL6A1 COL6A3 ITCH LAMA2 EXTL3 HNRNPH1 UBA1 WDR11 DCHS1 FZD2 | 9.42e-06 | 282 | 57 | 13 | HP:0009811 |
| Domain | MHC_II_b_N | 1.60e-05 | 8 | 125 | 3 | PD000328 | |
| Domain | MHC_II_b_N | 2.39e-05 | 9 | 125 | 3 | IPR000353 | |
| Domain | MHC_II_beta | 2.39e-05 | 9 | 125 | 3 | SM00921 | |
| Domain | MHC_II_beta | 2.39e-05 | 9 | 125 | 3 | PF00969 | |
| Domain | DUF5050 | 4.44e-05 | 2 | 125 | 2 | IPR032485 | |
| Domain | DUF5050 | 4.44e-05 | 2 | 125 | 2 | PF16472 | |
| Domain | MHC_II_a/b_N | 1.01e-04 | 14 | 125 | 3 | IPR014745 | |
| Domain | - | 1.01e-04 | 14 | 125 | 3 | 3.10.320.10 | |
| Domain | CADHERIN_1 | 1.12e-04 | 113 | 125 | 6 | PS00232 | |
| Domain | Cadherin | 1.12e-04 | 113 | 125 | 6 | PF00028 | |
| Domain | CADHERIN_2 | 1.18e-04 | 114 | 125 | 6 | PS50268 | |
| Domain | - | 1.18e-04 | 114 | 125 | 6 | 2.60.40.60 | |
| Domain | CA | 1.24e-04 | 115 | 125 | 6 | SM00112 | |
| Domain | Cadherin-like | 1.30e-04 | 116 | 125 | 6 | IPR015919 | |
| Domain | Cadherin | 1.42e-04 | 118 | 125 | 6 | IPR002126 | |
| Domain | VWFA | 2.24e-04 | 82 | 125 | 5 | PS50234 | |
| Domain | VWA | 2.51e-04 | 84 | 125 | 5 | SM00327 | |
| Domain | VWF_A | 5.36e-04 | 99 | 125 | 5 | IPR002035 | |
| Domain | VWA | 5.37e-04 | 56 | 125 | 4 | PF00092 | |
| Domain | cEGF | 6.80e-04 | 26 | 125 | 3 | PF12662 | |
| Domain | cEGF | 6.80e-04 | 26 | 125 | 3 | IPR026823 | |
| Domain | Cadherin_CS | 8.31e-04 | 109 | 125 | 5 | IPR020894 | |
| Domain | Cullin_CS | 9.13e-04 | 7 | 125 | 2 | IPR016157 | |
| Domain | CULLIN | 9.13e-04 | 7 | 125 | 2 | SM00182 | |
| Domain | Cullin_neddylation_domain | 1.21e-03 | 8 | 125 | 2 | IPR019559 | |
| Domain | Cullin_Nedd8 | 1.21e-03 | 8 | 125 | 2 | PF10557 | |
| Domain | Cullin_Nedd8 | 1.21e-03 | 8 | 125 | 2 | SM00884 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.52e-05 | 114 | 99 | 7 | MM14571 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | CAPN9 COL5A2 COL6A1 COL6A3 LAMA2 ITGAM SCUBE1 ELANE MMP8 TNXB | 4.80e-05 | 300 | 99 | 10 | M610 |
| Pathway | BIOCARTA_BBCELL_PATHWAY | 5.32e-05 | 11 | 99 | 3 | M22030 | |
| Pathway | BIOCARTA_EOSINOPHILS_PATHWAY | 5.32e-05 | 11 | 99 | 3 | M22048 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 5.70e-05 | 140 | 99 | 7 | M587 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 6.44e-05 | 98 | 99 | 6 | M965 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 8.26e-05 | 258 | 99 | 9 | MM14572 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 8.47e-05 | 64 | 99 | 5 | M26953 | |
| Pathway | BIOCARTA_IL5_PATHWAY | 9.13e-05 | 13 | 99 | 3 | M18928 | |
| Pathway | BIOCARTA_MHC_PATHWAY | 1.16e-04 | 14 | 99 | 3 | M22023 | |
| Pathway | BIOCARTA_BLYMPHOCYTE_PATHWAY | 1.16e-04 | 14 | 99 | 3 | M1473 | |
| Pathway | BIOCARTA_TCRA_PATHWAY | 1.16e-04 | 14 | 99 | 3 | M10765 | |
| Pathway | BIOCARTA_ASBCELL_PATHWAY | 1.44e-04 | 15 | 99 | 3 | M7298 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_NFY_MEDIATED_TRANSCRIPTION | 1.44e-04 | 15 | 99 | 3 | M47588 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_II_MOLECULES | 1.44e-04 | 15 | 99 | 3 | M47604 | |
| Pathway | KEGG_LEISHMANIA_INFECTION | 1.49e-04 | 72 | 99 | 5 | M3126 | |
| Pathway | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | 1.56e-04 | 39 | 99 | 4 | M16523 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.92e-04 | 76 | 99 | 5 | M27219 | |
| Pathway | PID_UPA_UPAR_PATHWAY | 2.09e-04 | 42 | 99 | 4 | M174 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 2.29e-04 | 43 | 99 | 4 | M39565 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 3.07e-04 | 84 | 99 | 5 | M7098 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 3.24e-04 | 47 | 99 | 4 | MM14925 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 3.51e-04 | 20 | 99 | 3 | MM15061 | |
| Pathway | BIOCARTA_CSK_PATHWAY | 4.70e-04 | 22 | 99 | 3 | M6327 | |
| Pathway | BIOCARTA_CTLA4_PATHWAY | 4.70e-04 | 22 | 99 | 3 | M1467 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 5.15e-04 | 53 | 99 | 4 | MM14566 | |
| Pathway | BIOCARTA_TH1TH2_PATHWAY | 5.37e-04 | 23 | 99 | 3 | M6705 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 6.80e-04 | 57 | 99 | 4 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 7.26e-04 | 58 | 99 | 4 | M2049 | |
| Pathway | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | 8.69e-04 | 27 | 99 | 3 | MM14809 | |
| Pathway | REACTOME_PD_1_SIGNALING | 9.69e-04 | 28 | 99 | 3 | M18810 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | CHL1 GPLD1 COL6A1 COL6A3 FLOT2 ITCH CILP GATM LCAT ITGAM ITIH4 B4GALT1 ABCB1 UBA1 ELANE TNXB CDH11 KNG1 C11orf52 | 1.30e-08 | 1070 | 127 | 19 | 23533145 |
| Pubmed | 3.99e-08 | 257 | 127 | 10 | 16335952 | ||
| Pubmed | Recent origin of HLA-DRB1 alleles and implications for human evolution. | 4.76e-08 | 3 | 127 | 3 | 9500545 | |
| Pubmed | A novel DRB1*09 allelic sequence in the Jing ethnic minority of China. | 4.76e-08 | 3 | 127 | 3 | 12121280 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 19811438 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 3099214 | ||
| Pubmed | A novel HLA-DRB1*09 allele, HLA-DRB1*090103*, isolated from the Han population of Guangdong, China. | 4.76e-08 | 3 | 127 | 3 | 15730527 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 20193583 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 16441501 | ||
| Pubmed | Complete cDNA sequences of the HLA-DRB1*0402 and DRB1*11041 alleles. | 4.76e-08 | 3 | 127 | 3 | 12358860 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 1428007 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 7652736 | ||
| Pubmed | Allelic diversity is generated by intraexon sequence exchange at the DRB1 locus of primates. | 4.76e-08 | 3 | 127 | 3 | 2023919 | |
| Pubmed | Shared class II MHC polymorphisms between humans and chimpanzees. | 4.76e-08 | 3 | 127 | 3 | 2511168 | |
| Pubmed | 6.99e-08 | 146 | 127 | 8 | 27068509 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 7.17e-08 | 97 | 127 | 7 | 27559042 | |
| Pubmed | 1.00e-07 | 153 | 127 | 8 | 25037231 | ||
| Pubmed | Allelic variation in the DR subregion of the human major histocompatibility complex. | 1.90e-07 | 4 | 127 | 3 | 3476943 | |
| Pubmed | 1.90e-07 | 4 | 127 | 3 | 26740600 | ||
| Pubmed | Analysis of DR beta and DQ beta chain cDNA clones from a DR7 haplotype. | 1.90e-07 | 4 | 127 | 3 | 3020127 | |
| Pubmed | HLA-DRB alleles and systemic lupus erythematosus in Jamaicans. | 1.90e-07 | 4 | 127 | 3 | 12144077 | |
| Pubmed | 1.90e-07 | 4 | 127 | 3 | 18520346 | ||
| Pubmed | Deficiency of tenascin-X causes a decrease in the level of expression of type VI collagen. | 1.90e-07 | 4 | 127 | 3 | 15194424 | |
| Pubmed | 4.73e-07 | 5 | 127 | 3 | 17910142 | ||
| Pubmed | 4.73e-07 | 5 | 127 | 3 | 16973583 | ||
| Pubmed | Genetic variability in HIV-1 gp120 affects interactions with HLA molecules and T cell receptor. | 4.73e-07 | 5 | 127 | 3 | 1970352 | |
| Pubmed | 4.73e-07 | 5 | 127 | 3 | 7645219 | ||
| Pubmed | 4.73e-07 | 5 | 127 | 3 | 12392858 | ||
| Pubmed | 4.73e-07 | 5 | 127 | 3 | 12209103 | ||
| Pubmed | HLA-DQA is associated with abdominal aortic aneurysms in the Belgian population. | 4.73e-07 | 5 | 127 | 3 | 17182961 | |
| Pubmed | 4.73e-07 | 5 | 127 | 3 | 11782380 | ||
| Pubmed | 4.73e-07 | 5 | 127 | 3 | 23152536 | ||
| Pubmed | 4.73e-07 | 5 | 127 | 3 | 17411376 | ||
| Pubmed | Productive human immunodeficiency virus type 1 assembly takes place at the plasma membrane. | 4.73e-07 | 5 | 127 | 3 | 17507489 | |
| Pubmed | 4.73e-07 | 5 | 127 | 3 | 7734415 | ||
| Pubmed | Visual hallucinations and HLA class II antigens in cortical dementia. | 4.73e-07 | 5 | 127 | 3 | 20606439 | |
| Pubmed | HLA-DR and DQB1 gene polymorphism in the North-western Colombian population. | 4.73e-07 | 5 | 127 | 3 | 12144632 | |
| Pubmed | HIV-1 gag polyprotein rescues HLA-DR intracellular transport in a human CD4+ cell line. | 4.73e-07 | 5 | 127 | 3 | 12202216 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 6.89e-07 | 135 | 127 | 7 | 28675934 | |
| Pubmed | 9.43e-07 | 6 | 127 | 3 | 17153701 | ||
| Pubmed | 9.43e-07 | 6 | 127 | 3 | 18305173 | ||
| Pubmed | 9.43e-07 | 6 | 127 | 3 | 15902698 | ||
| Pubmed | HLA risk markers for chronic myelogenous leukemia in Eastern Canada. | 9.43e-07 | 6 | 127 | 3 | 19235017 | |
| Pubmed | 9.43e-07 | 6 | 127 | 3 | 11082517 | ||
| Pubmed | 9.43e-07 | 6 | 127 | 3 | 15896200 | ||
| Pubmed | 9.43e-07 | 6 | 127 | 3 | 11997714 | ||
| Pubmed | HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. | 9.43e-07 | 6 | 127 | 3 | 14508706 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | RAF1 FLOT2 ITCH RHBDF1 ERCC6L DNAJC16 ADCY6 TULP3 ABCB1 VANGL2 LSR C11orf52 | 1.28e-06 | 569 | 127 | 12 | 30639242 |
| Pubmed | 1.65e-06 | 7 | 127 | 3 | 18569076 | ||
| Pubmed | 1.65e-06 | 7 | 127 | 3 | 1905983 | ||
| Pubmed | Human macrophages accumulate HIV-1 particles in MHC II compartments. | 1.65e-06 | 7 | 127 | 3 | 12230470 | |
| Pubmed | [Human leukocyte antigen genes to genetic predisposition in diffuse panbronchiolitis]. | 1.65e-06 | 7 | 127 | 3 | 18846964 | |
| Pubmed | 1.65e-06 | 7 | 127 | 3 | 20307907 | ||
| Pubmed | 2.63e-06 | 8 | 127 | 3 | 19223392 | ||
| Pubmed | In vivo evidence for a bridging role of a collagen V subtype at the epidermis-dermis interface. | 2.63e-06 | 8 | 127 | 3 | 22437311 | |
| Pubmed | Correlation between HLA and pityriasis rosea susceptibility in Brazilian blacks. | 2.63e-06 | 8 | 127 | 3 | 16405603 | |
| Pubmed | 2.63e-06 | 8 | 127 | 3 | 12296785 | ||
| Pubmed | 2.63e-06 | 8 | 127 | 3 | 17106278 | ||
| Pubmed | A mouse model for dominant collagen VI disorders: heterozygous deletion of Col6a3 Exon 16. | 2.63e-06 | 8 | 127 | 3 | 24563484 | |
| Pubmed | 2.63e-06 | 8 | 127 | 3 | 23729440 | ||
| Pubmed | 2.86e-06 | 167 | 127 | 7 | 22159717 | ||
| Pubmed | 3.89e-06 | 175 | 127 | 7 | 28071719 | ||
| Pubmed | 3.93e-06 | 9 | 127 | 3 | 24505475 | ||
| Pubmed | 3.93e-06 | 9 | 127 | 3 | 23170932 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | CUL4B CUL4A FLOT2 ERCC6L GATM CCT7 HNRNPH1 B4GALT1 PCF11 MISP UBA1 KAT8 COG5 TOP2B AQR KIF1C | 5.09e-06 | 1155 | 127 | 16 | 20360068 |
| Pubmed | 5.60e-06 | 10 | 127 | 3 | 15784911 | ||
| Pubmed | 5.60e-06 | 10 | 127 | 3 | 12956878 | ||
| Pubmed | 5.60e-06 | 10 | 127 | 3 | 8450224 | ||
| Pubmed | The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis. | 5.60e-06 | 10 | 127 | 3 | 15345741 | |
| Pubmed | 5.63e-06 | 32 | 127 | 4 | 23154389 | ||
| Pubmed | 7.68e-06 | 11 | 127 | 3 | 21085635 | ||
| Pubmed | 7.68e-06 | 11 | 127 | 3 | 22808111 | ||
| Pubmed | 1.02e-05 | 12 | 127 | 3 | 11908948 | ||
| Pubmed | 1.02e-05 | 12 | 127 | 3 | 16872848 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 2592019 | ||
| Pubmed | Interaction of H-2Eb with an IAP retrotransposon in the A20/2J B cell lymphoma. | 1.32e-05 | 2 | 127 | 2 | 1353478 | |
| Pubmed | Complete cDNA sequences of the HLA-DRB1*14011, *1402, *1403 and *1404 alleles. | 1.32e-05 | 2 | 127 | 2 | 11972886 | |
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 1.32e-05 | 2 | 127 | 2 | 15963947 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 12028548 | ||
| Pubmed | Effects of Advancing Gestation and Non-Caucasian Race on Ductus Arteriosus Gene Expression. | 1.32e-05 | 2 | 127 | 2 | 26265282 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 3150763 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 9777332 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 3596674 | ||
| Pubmed | Isolation and characterization of a cDNA clone for the murine I-E beta polypeptide chain. | 1.32e-05 | 2 | 127 | 2 | 6324181 | |
| Pubmed | Mouse MHC class II gene E beta 2 is closely related to E beta and to HLA-DR beta. | 1.32e-05 | 2 | 127 | 2 | 2989167 | |
| Pubmed | COL6A and LAMA2 Mutation Congenital Muscular Dystrophy: A Clinical and Electrophysiological Study. | 1.32e-05 | 2 | 127 | 2 | 29465610 | |
| Pubmed | Structural organization of the DR subregion of the human major histocompatibility complex. | 1.32e-05 | 2 | 127 | 2 | 3860851 | |
| Pubmed | HLA-DR2 subtypes form an additional supertypic family of DR beta alleles. | 1.32e-05 | 2 | 127 | 2 | 2885840 | |
| Pubmed | Mac-1 (CD11b/CD18) links inflammation and thrombosis after glomerular injury. | 1.32e-05 | 2 | 127 | 2 | 19752320 | |
| Pubmed | HLA-DR4 as a risk allele for autism acting in mothers of probands possibly during pregnancy. | 1.32e-05 | 2 | 127 | 2 | 19487610 | |
| Pubmed | Dysregulation of CUL4A and CUL4B Ubiquitin Ligases in Lung Cancer. | 1.32e-05 | 2 | 127 | 2 | 27974468 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 20164547 | ||
| Pubmed | Bethlem myopathy: a series of 16 patients and description of seven new associated mutations. | 1.32e-05 | 2 | 127 | 2 | 30706156 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 33188786 | ||
| Pubmed | Identification of two novel HLA-DRB1 alleles, DRB1*0903 and DRB1*1145. | 1.32e-05 | 2 | 127 | 2 | 15191532 | |
| Pubmed | Identification of a novel HLA-DRB1 allele (HLA-DRB1*111902*). | 1.32e-05 | 2 | 127 | 2 | 15982264 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 15982265 | ||
| Pubmed | H2-Eb1 expression is upregulated in the nasal mucosa of allergic rhinitis. | 1.32e-05 | 2 | 127 | 2 | 25543041 | |
| Pubmed | Unique sequences for two HLA-DRB1 genes expressed on distinct DRw6 haplotypes. | 1.32e-05 | 2 | 127 | 2 | 1975801 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 15140072 | ||
| Interaction | SERPINE1 interactions | 8.86e-07 | 54 | 122 | 6 | int:SERPINE1 | |
| Interaction | RING1 interactions | 3.77e-06 | 201 | 122 | 9 | int:RING1 | |
| Interaction | HSPA7 interactions | 5.32e-06 | 73 | 122 | 6 | int:HSPA7 | |
| Interaction | WDR82 interactions | 6.04e-06 | 213 | 122 | 9 | int:WDR82 | |
| Interaction | RHBDD1 interactions | SLC66A2 ITCH KRT18 PCDHGB5 DNAJC16 ITGAM ITIH4 VANGL2 ELANE MMP8 KNG1 | 8.38e-06 | 346 | 122 | 11 | int:RHBDD1 |
| Interaction | HARS1 interactions | 1.23e-05 | 127 | 122 | 7 | int:HARS1 | |
| Interaction | PDLIM2 interactions | 1.24e-05 | 24 | 122 | 4 | int:PDLIM2 | |
| Interaction | BRWD3 interactions | 1.28e-05 | 50 | 122 | 5 | int:BRWD3 | |
| Interaction | MMP2 interactions | 1.47e-05 | 87 | 122 | 6 | int:MMP2 | |
| Interaction | FN3KRP interactions | 2.65e-05 | 58 | 122 | 5 | int:FN3KRP | |
| Interaction | RBMXL3 interactions | 3.45e-05 | 11 | 122 | 3 | int:RBMXL3 | |
| Interaction | TAF15 interactions | CUL4B CUL4A RAF1 ITCH MCM2 CIT HNRNPC HNRNPH1 MEPCE TOP2B AQR | 3.84e-05 | 408 | 122 | 11 | int:TAF15 |
| Interaction | TUBA4B interactions | 5.79e-05 | 35 | 122 | 4 | int:TUBA4B | |
| Interaction | PHAX interactions | 7.13e-05 | 167 | 122 | 7 | int:PHAX | |
| Interaction | ATAD3C interactions | 7.23e-05 | 37 | 122 | 4 | int:ATAD3C | |
| Interaction | BUB3 interactions | 8.53e-05 | 232 | 122 | 8 | int:BUB3 | |
| Interaction | H2AC16 interactions | 1.14e-04 | 16 | 122 | 3 | int:H2AC16 | |
| Interaction | H2AC15 interactions | 1.14e-04 | 16 | 122 | 3 | int:H2AC15 | |
| Interaction | TUBB4A interactions | 1.21e-04 | 244 | 122 | 8 | int:TUBB4A | |
| Interaction | GRWD1 interactions | 1.32e-04 | 390 | 122 | 10 | int:GRWD1 | |
| Interaction | EEF1E1 interactions | 1.35e-04 | 129 | 122 | 6 | int:EEF1E1 | |
| Interaction | EZR interactions | FLOT2 ANK3 DGKQ MCM2 ELP3 CIT HNRNPH1 VANGL2 LSR MISP UBA1 TAB1 | 1.36e-04 | 553 | 122 | 12 | int:EZR |
| GeneFamily | Immunoglobulin like domain containing | 4.30e-04 | 193 | 91 | 6 | 594 | |
| GeneFamily | Cullins | 6.88e-04 | 8 | 91 | 2 | 1032 | |
| GeneFamily | C1-set domain containing | 1.23e-03 | 42 | 91 | 3 | 591 | |
| GeneFamily | ATP binding cassette subfamily B | 1.34e-03 | 11 | 91 | 2 | 806 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 1.41e-03 | 44 | 91 | 3 | 588 | |
| GeneFamily | Collagens | 1.60e-03 | 46 | 91 | 3 | 490 | |
| GeneFamily | Low density lipoprotein receptors | 1.89e-03 | 13 | 91 | 2 | 634 | |
| GeneFamily | Cadherin related | 3.24e-03 | 17 | 91 | 2 | 24 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.24e-03 | 17 | 91 | 2 | 486 | |
| GeneFamily | Clustered protocadherins | 4.12e-03 | 64 | 91 | 3 | 20 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 6.59e-07 | 35 | 125 | 5 | M11788 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 7.62e-07 | 36 | 125 | 5 | MM1212 | |
| Coexpression | LEE_BMP2_TARGETS_UP | COL6A1 ANK3 KRT18 CILP LAMA2 GRB7 BCKDHA EXTL3 H6PD ADCY6 ABCB1 PLAAT3 DCHS1 LRP1 PDLIM2 TNXB | 9.88e-07 | 780 | 125 | 16 | M2324 |
| Coexpression | LEE_BMP2_TARGETS_UP | COL6A1 ANK3 KRT18 CILP LAMA2 GRB7 BCKDHA EXTL3 H6PD ADCY6 ABCB1 PLAAT3 DCHS1 LRP1 PDLIM2 TNXB | 1.49e-06 | 805 | 125 | 16 | MM1067 |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C2 | 2.77e-06 | 21 | 125 | 4 | M4767 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 4.69e-06 | 261 | 125 | 9 | M1834 | |
| Coexpression | BARIS_THYROID_CANCER_DN | 9.27e-06 | 59 | 125 | 5 | M15411 | |
| Coexpression | WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP | 2.56e-05 | 121 | 125 | 6 | M8475 | |
| Coexpression | CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN | CHL1 CNTN4 DNAJC16 GATM PLAAT3 AGO3 SAMD13 TRIM38 C11orf52 KIF1C | 2.65e-05 | 407 | 125 | 10 | M2214 |
| Coexpression | ONDER_CDH1_TARGETS_2_UP | 3.36e-05 | 257 | 125 | 8 | M13867 | |
| Coexpression | NABA_CORE_MATRISOME | 4.75e-05 | 270 | 125 | 8 | MM17057 | |
| Coexpression | GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP | 4.90e-05 | 199 | 125 | 7 | M4444 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | COL5A2 COL6A1 COL6A3 CILP HLA-DRB1 HLA-DRB4 FZD2 PDLIM2 CDH11 | 5.00e-05 | 352 | 125 | 9 | M17471 |
| Coexpression | NABA_CORE_MATRISOME | 5.41e-05 | 275 | 125 | 8 | M5884 | |
| Coexpression | WESTON_VEGFA_TARGETS_6HR | 9.58e-05 | 50 | 125 | 4 | M1521 | |
| Coexpression | CAIRO_LIVER_DEVELOPMENT_DN | 1.06e-04 | 225 | 125 | 7 | M6175 | |
| Coexpression | WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER | 1.12e-04 | 52 | 125 | 4 | M19766 | |
| Coexpression | VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 | 1.30e-04 | 54 | 125 | 4 | M4737 | |
| Coexpression | SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_1DY_UP | 1.32e-04 | 21 | 125 | 3 | M41167 | |
| Coexpression | REN_ALVEOLAR_RHABDOMYOSARCOMA_DN | 1.51e-04 | 407 | 125 | 9 | M19541 | |
| Coexpression | CAIRO_LIVER_DEVELOPMENT_DN | 1.54e-04 | 239 | 125 | 7 | MM1274 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 1.96e-05 | 97 | 121 | 6 | GSM777046_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.31e-05 | 336 | 121 | 10 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.89e-10 | 191 | 126 | 10 | 24dc77ee8de01b42559f92721655f4281b114e17 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.99e-10 | 192 | 126 | 10 | 29bee88b45e23f16543ffc7cc361bc5da5d16a2b | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.99e-10 | 192 | 126 | 10 | cdc652dbfabe41b324fd85c1ed933d29fb73a49f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.55e-10 | 197 | 126 | 10 | 71786e9432e2d649f5d86f639abb25e7102deb67 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | CHL1 CNTN4 FNDC3B COL5A2 COL6A1 COL6A3 CLSTN3 LRP1 TNXB CDH11 | 2.82e-10 | 199 | 126 | 10 | 8b86c69aaf60feff53aa782559cfece7342a23de |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.61e-09 | 182 | 126 | 9 | d179b5deb07c20d49eb6c58d5a65904f8921de3a | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-09 | 186 | 126 | 9 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.31e-09 | 187 | 126 | 9 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Fibroblasts|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.47e-09 | 129 | 126 | 8 | 13cd10ffdd8f1ef7721884e9efd2cf25f170f414 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-09 | 189 | 126 | 9 | 544d95df910f1b276995624509a7e41b219baca0 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.80e-09 | 190 | 126 | 9 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-09 | 191 | 126 | 9 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-09 | 192 | 126 | 9 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-09 | 192 | 126 | 9 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.36e-09 | 193 | 126 | 9 | 9d0b966d13cbce97beb43de6dc77f006c363a181 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-09 | 193 | 126 | 9 | 49600db68ed65cafc67bd45a285b364e4f5f88af | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 4.36e-09 | 193 | 126 | 9 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.56e-09 | 194 | 126 | 9 | 5594f7437448cb4b37d2d100f44d30c4a367df26 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.21e-09 | 197 | 126 | 9 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.45e-09 | 198 | 126 | 9 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.69e-09 | 199 | 126 | 9 | 9672230aa0bc6a7289050c955f5154ca183a5159 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.69e-09 | 199 | 126 | 9 | e18abe678da293bd01fae55e2f9ab6fdd643d02d | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.69e-09 | 199 | 126 | 9 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.69e-09 | 199 | 126 | 9 | 1fd7bbb8727607e6507848602a19bc86882ef2d5 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.95e-09 | 200 | 126 | 9 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.95e-09 | 200 | 126 | 9 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.32e-08 | 172 | 126 | 8 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.96e-08 | 176 | 126 | 8 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.96e-08 | 176 | 126 | 8 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 4.33e-08 | 178 | 126 | 8 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.59e-08 | 184 | 126 | 8 | 01257e5c12e38b849fd3d9496c43ded666249ba5 | |
| ToppCell | E12.5-Epithelial-airway_epithelial_cell-club_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.59e-08 | 184 | 126 | 8 | a69c3c57cd939b2888f548a0fbca3392ad310445 | |
| ToppCell | E12.5-Epithelial-airway_epithelial_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.59e-08 | 184 | 126 | 8 | 3df78b17098b50e1a7f2c8791bf2d0806328330a | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.83e-08 | 185 | 126 | 8 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.83e-08 | 185 | 126 | 8 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.83e-08 | 185 | 126 | 8 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.08e-08 | 186 | 126 | 8 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.08e-08 | 186 | 126 | 8 | 7582b5154d8e5a4434817b5ab77a10b789ea2288 | |
| ToppCell | Fibroblast-C|World / shred on cell class and cell subclass (v4) | 6.88e-08 | 189 | 126 | 8 | 58e0400fbab5a0755504275aef5cf7986149abab | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.88e-08 | 189 | 126 | 8 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.88e-08 | 189 | 126 | 8 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.88e-08 | 189 | 126 | 8 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.88e-08 | 189 | 126 | 8 | eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.88e-08 | 189 | 126 | 8 | 40764f461b8aa1d3a2c5a30590b7fb9307d47d09 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.88e-08 | 189 | 126 | 8 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | droplet-Lung-18m-Mesenchymal|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.16e-08 | 190 | 126 | 8 | 0b7200897b2c389632c9b1ee37e272b811555dbc | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.16e-08 | 190 | 126 | 8 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.46e-08 | 191 | 126 | 8 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 7.46e-08 | 191 | 126 | 8 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.46e-08 | 191 | 126 | 8 | cd497abed9e00e4e0becd9dbc036c6e7a60ae791 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.46e-08 | 191 | 126 | 8 | 9f478f36a0b895e607e3bb77fa0f9f03cc0f33fc | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 7.46e-08 | 191 | 126 | 8 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.46e-08 | 191 | 126 | 8 | 997abf0cc5873bed0372c4a333ed307fa72774d2 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.76e-08 | 192 | 126 | 8 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.76e-08 | 192 | 126 | 8 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | facs-Lung-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.76e-08 | 192 | 126 | 8 | 8df15085b35b86f39debd933284cb703c5dd63c2 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.76e-08 | 192 | 126 | 8 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.76e-08 | 192 | 126 | 8 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.76e-08 | 192 | 126 | 8 | 2d9e2262f1342fe17735f21f733c029d1275e955 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.76e-08 | 192 | 126 | 8 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.08e-08 | 193 | 126 | 8 | 316ebdf15f75d88c348f909b643fcd315364ca84 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.08e-08 | 193 | 126 | 8 | 1afdd3f7d703f4204a2cbfe40e135ac7b09213f7 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.08e-08 | 193 | 126 | 8 | 5bee7abc550ddaa28cbb3b9ecaf6b924ab175de0 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.08e-08 | 193 | 126 | 8 | d9c20a092b507c43fcf7ccb04073fecd27d1749c | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.08e-08 | 193 | 126 | 8 | fe9720185929ef849edd1b8eb4854306b392e5a2 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.08e-08 | 193 | 126 | 8 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.08e-08 | 193 | 126 | 8 | 8dc6db335678f3a5cfd36026ad811fed8d9cb4bc | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.08e-08 | 193 | 126 | 8 | 051f61156b0e2e95292b2d8377faf3190b50f264 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.08e-08 | 193 | 126 | 8 | 45b5cab4dfeb0ed3b13631db5963740a792b810f | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Mesenchymal|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 8.41e-08 | 194 | 126 | 8 | 638b9fdce64ed00243b5303800ec66207d5fd640 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Mesenchymal-choroid_plexus/mesenchymal-like_cells|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 8.41e-08 | 194 | 126 | 8 | e9868c22934b6c0ac35e3e8270ec0b671bc6582a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.41e-08 | 194 | 126 | 8 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 8.41e-08 | 194 | 126 | 8 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.41e-08 | 194 | 126 | 8 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.41e-08 | 194 | 126 | 8 | 02b8102be9414d6964cd71019613edff6d88b893 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.41e-08 | 194 | 126 | 8 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.41e-08 | 194 | 126 | 8 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.75e-08 | 195 | 126 | 8 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.75e-08 | 195 | 126 | 8 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.75e-08 | 195 | 126 | 8 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.10e-08 | 196 | 126 | 8 | 617103f4a09e009fe96c28eb5e40505a4fd6dcf4 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.10e-08 | 196 | 126 | 8 | db64ab27374f82553ee577aec056141170f3656f | |
| ToppCell | background-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.84e-08 | 198 | 126 | 8 | 79f32f965aed6a10c5cb803173e3db7b32e07a91 | |
| ToppCell | tumor_Lung-Fibroblasts-COL14A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 9.84e-08 | 198 | 126 | 8 | 74f2c7ef702b25a5b99e56121229e678ed992524 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.84e-08 | 198 | 126 | 8 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.02e-07 | 199 | 126 | 8 | ba586690f88fd051f449753bfe7603a2cb431782 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 1.02e-07 | 199 | 126 | 8 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.02e-07 | 199 | 126 | 8 | 38ed3bc7daa993d9edcf3e7834597ebb06dd24f8 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.02e-07 | 199 | 126 | 8 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 | |
| ToppCell | Fibroblasts|World / lung cells shred on cell class, cell subclass, sample id | 1.02e-07 | 199 | 126 | 8 | e2b6752fcabd5249a166486ae6796f2c97c1fcaf | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.02e-07 | 199 | 126 | 8 | fcbb3a9c0f4c5b4c1f09db24b9f50cc1166fa43b | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.02e-07 | 199 | 126 | 8 | 95d95e9b7bd3933188998ae94986213eb0f1e5ea | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.02e-07 | 199 | 126 | 8 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.02e-07 | 199 | 126 | 8 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-07 | 199 | 126 | 8 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-07 | 199 | 126 | 8 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | (5)_Fibroblast-D|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.02e-07 | 199 | 126 | 8 | 3f415620ad8b8d8c6871e1353e13f87b281fcc0e | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.06e-07 | 200 | 126 | 8 | 747c61d4e0b746278ae1f45ca4cd556c6961c76a | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-07 | 200 | 126 | 8 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-07 | 200 | 126 | 8 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| Computational | Liver genes - metabolism and xenobiotics. | GPLD1 COL6A1 KRT18 GATM GRB7 BCKDHA LCAT ELAC2 ITIH4 DCHS1 LRP1 ANXA9 TNXB KNG1 | 1.06e-04 | 563 | 84 | 14 | MODULE_23 |
| Computational | Adhesion molecules. | 1.12e-04 | 141 | 84 | 7 | MODULE_122 | |
| Computational | Fetal liver genes - metabolism and xenobiotics. | COL5A2 COL6A1 COL6A3 KRT18 GATM MCM2 LCAT ITIH4 LRP1 ANXA9 TNXB KNG1 | 1.94e-04 | 453 | 84 | 12 | MODULE_24 |
| Drug | LMWH | COL6A1 COL6A3 RHBDF1 PNLIP KRT18 POLRMT LAMA2 EXTL3 LCAT ITGAM ADCY6 ITIH4 POLR3E LRP1 ELANE TNXB NOS3 | 1.72e-07 | 663 | 127 | 17 | CID000000772 |
| Drug | AC1L1B55 | RAF1 ENOX1 KRT18 ITGAM HNRNPC HNRNPH1 ABCB1 POLR3E ELANE MMP8 NOS3 TOP2B SLX1A ENOX2 | 2.56e-07 | 454 | 127 | 14 | CID000001287 |
| Drug | Moxalactam disodium salt [64953-12-4]; Up 200; 7uM; HL60; HT_HG-U133A | 1.53e-06 | 195 | 127 | 9 | 3028_UP | |
| Drug | estradiol, USP; Down 200; 0.1uM; HL60; HT_HG-U133A | 1.67e-06 | 197 | 127 | 9 | 2668_DN | |
| Drug | famoxadone | 3.35e-06 | 19 | 127 | 4 | CID000213032 | |
| Drug | hexanamide | 4.75e-06 | 119 | 127 | 7 | CID000012332 | |
| Drug | lumiracoxib | 5.84e-06 | 7 | 127 | 3 | ctd:C473384 | |
| Drug | Palladium | 5.84e-06 | 7 | 127 | 3 | ctd:D010165 | |
| Drug | WEB 2347 | 5.84e-06 | 7 | 127 | 3 | CID003081067 | |
| Drug | KRN8602 | 9.30e-06 | 8 | 127 | 3 | CID000107869 | |
| Drug | AC1L1O6Q | 1.45e-05 | 141 | 127 | 7 | CID000058035 | |
| Drug | Vancomycin hydrochloride [1404-93-9]; Down 200; 2.6uM; MCF7; HT_HG-U133A | 1.46e-05 | 196 | 127 | 8 | 4423_DN | |
| Drug | Bromopride [4093-35-0]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.46e-05 | 196 | 127 | 8 | 4741_UP | |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; HL60; HT_HG-U133A | 1.52e-05 | 197 | 127 | 8 | 2176_DN | |
| Drug | (S)-propranolol hydrochloride [4199-10-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 1.57e-05 | 198 | 127 | 8 | 3523_UP | |
| Drug | Amiloride hydrochloride dihydrate [17440-83-4]; Up 200; 13.2uM; HL60; HG-U133A | 1.63e-05 | 199 | 127 | 8 | 1970_UP | |
| Drug | azidopine | 1.70e-05 | 28 | 127 | 4 | CID000656406 | |
| Drug | AC1L1O7J | 2.60e-05 | 104 | 127 | 6 | CID000007189 | |
| Drug | AC1L9HHR | 3.04e-05 | 354 | 127 | 10 | CID000445141 | |
| Drug | 1-methyl-2-undecyl-4-quinolone | 3.09e-05 | 2 | 127 | 2 | CID005319811 | |
| Drug | AC1L8X8E | 3.09e-05 | 2 | 127 | 2 | CID000434318 | |
| Drug | AC1L8X8B | 3.09e-05 | 2 | 127 | 2 | CID000434317 | |
| Drug | AC1L9236 | 3.09e-05 | 2 | 127 | 2 | CID000411789 | |
| Drug | psorospermin | 3.09e-05 | 2 | 127 | 2 | CID000126451 | |
| Drug | moflomycin | 3.09e-05 | 2 | 127 | 2 | CID000163775 | |
| Drug | NSC348400 | 3.09e-05 | 2 | 127 | 2 | CID000335945 | |
| Drug | KW-2170 | 3.09e-05 | 2 | 127 | 2 | CID005747700 | |
| Drug | morpholinyldoxorubicin | 3.09e-05 | 2 | 127 | 2 | CID000092398 | |
| Drug | AC1L9K72 | 3.72e-05 | 290 | 127 | 9 | CID000446872 | |
| Drug | AC1L2NWK | 3.76e-05 | 34 | 127 | 4 | CID000075038 | |
| Drug | AC1L9732 | 4.36e-05 | 114 | 127 | 6 | CID000439300 | |
| Drug | Sistan | 4.74e-05 | 36 | 127 | 4 | CID003001858 | |
| Drug | genistein | PCSK1 GPLD1 RAF1 COL6A3 RHBDF1 LAMA2 PLCD4 EXTL3 ITGAM HNRNPC HNRNPH1 TULP3 ABCB1 ELANE MMP8 NOS3 TOP2B SLX1A | 4.85e-05 | 1117 | 127 | 18 | CID005280961 |
| Drug | lysophosphatidylglycerol | 5.29e-05 | 37 | 127 | 4 | CID000447308 | |
| Drug | atazanavir | 5.81e-05 | 120 | 127 | 6 | CID000148192 | |
| Drug | DAST | 5.90e-05 | 14 | 127 | 3 | CID000123472 | |
| Drug | gabexate mesilate | 6.09e-05 | 121 | 127 | 6 | CID000003447 | |
| Drug | butenal | 6.91e-05 | 180 | 127 | 7 | CID000020138 | |
| Drug | fluoroanilinoazatoxin | 9.23e-05 | 3 | 127 | 2 | CID000378896 | |
| Drug | merodantoin | 9.23e-05 | 3 | 127 | 2 | CID000134014 | |
| Drug | 2-(2-fluorobenzamido)benzoate ethyl ester | 9.23e-05 | 3 | 127 | 2 | ctd:C560790 | |
| Drug | NSC688503 | 9.23e-05 | 3 | 127 | 2 | CID000390744 | |
| Drug | BIBW22BS | 9.23e-05 | 3 | 127 | 2 | CID000132088 | |
| Drug | methylazatoxin | 9.23e-05 | 3 | 127 | 2 | CID000148162 | |
| Drug | Wp159 | 9.23e-05 | 3 | 127 | 2 | CID003060549 | |
| Drug | NSC5273 | 9.23e-05 | 3 | 127 | 2 | CID000012977 | |
| Drug | AC1NDLZU | 9.63e-05 | 43 | 127 | 4 | CID004627981 | |
| Drug | S(-)Eticlopride hydrochloride [97612-24-3]; Up 200; 10.6uM; PC3; HT_HG-U133A | 1.14e-04 | 195 | 127 | 7 | 4634_UP | |
| Drug | Naphazoline hydrochloride [550-99-2]; Up 200; 16.2uM; HL60; HG-U133A | 1.14e-04 | 195 | 127 | 7 | 1966_UP | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.18e-04 | 196 | 127 | 7 | 987_UP | |
| Drug | Famotidine [76824-35-6]; Up 200; 11.8uM; PC3; HT_HG-U133A | 1.22e-04 | 197 | 127 | 7 | 6665_UP | |
| Drug | Reserpine [50-55-5]; Down 200; 6.6uM; HL60; HT_HG-U133A | 1.25e-04 | 198 | 127 | 7 | 3003_DN | |
| Drug | Ticarcillin sodium [4697-14-7]; Up 200; 9.4uM; HL60; HT_HG-U133A | 1.25e-04 | 198 | 127 | 7 | 6146_UP | |
| Drug | Harmane hydrochloride [21655-84-5]; Up 200; 18.2uM; PC3; HT_HG-U133A | 1.25e-04 | 198 | 127 | 7 | 4584_UP | |
| Drug | Ranitidine hydrochloride [66357-59-3]; Up 200; 11.4uM; PC3; HT_HG-U133A | 1.29e-04 | 199 | 127 | 7 | 6324_UP | |
| Drug | Chlorthalidone [77-36-1]; Up 200; 11.8uM; HL60; HG-U133A | 1.29e-04 | 199 | 127 | 7 | 1581_UP | |
| Drug | PCR 4099 | 1.31e-04 | 139 | 127 | 6 | CID000002806 | |
| Drug | NSC350593 | 1.37e-04 | 269 | 127 | 8 | CID000004364 | |
| Drug | perillyl alcohol | 1.54e-04 | 19 | 127 | 3 | ctd:C032208 | |
| Disease | ubiquitin carboxyl-terminal hydrolase 25 measurement | 1.98e-06 | 22 | 123 | 4 | EFO_0021881 | |
| Disease | autism spectrum disorder, schizophrenia | CNTN4 GALNT10 HLA-DRB1 HLA-DRB5 HNRNPC ITIH4 PCNX1 KDM4A TNXB | 9.83e-06 | 327 | 123 | 9 | EFO_0003756, MONDO_0005090 |
| Disease | Ullrich congenital muscular dystrophy (implicated_via_orthology) | 1.72e-05 | 2 | 123 | 2 | DOID:0050558 (implicated_via_orthology) | |
| Disease | Hantavirus hemorrhagic fever with renal syndrome (is_implicated_in) | 1.72e-05 | 2 | 123 | 2 | DOID:11266 (is_implicated_in) | |
| Disease | endocrine system disease (implicated_via_orthology) | 1.72e-05 | 2 | 123 | 2 | DOID:28 (implicated_via_orthology) | |
| Disease | Fetal Alcohol Syndrome | 4.61e-05 | 17 | 123 | 3 | C0015923 | |
| Disease | neuromyelitis optica | 5.16e-05 | 3 | 123 | 2 | EFO_0004256 | |
| Disease | acute disseminated encephalomyelitis (is_implicated_in) | 5.16e-05 | 3 | 123 | 2 | DOID:639 (is_implicated_in) | |
| Disease | epilepsy (implicated_via_orthology) | 6.46e-05 | 163 | 123 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | systemic lupus erythematosus, COVID-19 | 1.02e-04 | 58 | 123 | 4 | MONDO_0007915, MONDO_0100096 | |
| Disease | Ullrich congenital muscular dystrophy | 1.03e-04 | 4 | 123 | 2 | cv:C4551860 | |
| Disease | AQP4-IgG-positive neuromyelitis optica | 1.03e-04 | 4 | 123 | 2 | EFO_0009584 | |
| Disease | Bethlem myopathy | 1.03e-04 | 4 | 123 | 2 | cv:C1834674 | |
| Disease | BETHLEM MYOPATHY 1 | 1.03e-04 | 4 | 123 | 2 | C1834674 | |
| Disease | Ullrich congenital muscular dystrophy 1 | 1.03e-04 | 4 | 123 | 2 | C0410179 | |
| Disease | vulva cancer (is_implicated_in) | 1.03e-04 | 4 | 123 | 2 | DOID:1245 (is_implicated_in) | |
| Disease | Bethlem myopathy (is_implicated_in) | 1.03e-04 | 4 | 123 | 2 | DOID:0050663 (is_implicated_in) | |
| Disease | Ullrich congenital muscular dystrophy (is_implicated_in) | 1.03e-04 | 4 | 123 | 2 | DOID:0050558 (is_implicated_in) | |
| Disease | Allergic Reaction | 1.42e-04 | 63 | 123 | 4 | C1527304 | |
| Disease | Hypersensitivity | 1.51e-04 | 64 | 123 | 4 | C0020517 | |
| Disease | complement C4b measurement | 1.52e-04 | 25 | 123 | 3 | EFO_0008092 | |
| Disease | keratoconus | 1.70e-04 | 66 | 123 | 4 | MONDO_0015486 | |
| Disease | hepatocyte nuclear factor 4-alpha measurement | 1.71e-04 | 5 | 123 | 2 | EFO_0801672 | |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 2.56e-04 | 6 | 123 | 2 | DOID:0050557 (implicated_via_orthology) | |
| Disease | glutamate receptor 4 measurement | 2.56e-04 | 6 | 123 | 2 | EFO_0801630 | |
| Disease | obesity (implicated_via_orthology) | 2.92e-04 | 215 | 123 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | contactin-4 measurement | 3.57e-04 | 7 | 123 | 2 | EFO_0020287 | |
| Disease | retinopathy of prematurity (is_implicated_in) | 3.57e-04 | 7 | 123 | 2 | DOID:13025 (is_implicated_in) | |
| Disease | MASA syndrome (implicated_via_orthology) | 3.57e-04 | 7 | 123 | 2 | DOID:0060246 (implicated_via_orthology) | |
| Disease | pack-years measurement, systolic blood pressure | 3.85e-04 | 34 | 123 | 3 | EFO_0006335, EFO_0006526 | |
| Disease | Behcet's disease (is_implicated_in) | 4.56e-04 | 36 | 123 | 3 | DOID:13241 (is_implicated_in) | |
| Disease | Muscular Dystrophy | 4.75e-04 | 8 | 123 | 2 | C0026850 | |
| Disease | interleukin-21 measurement | 4.75e-04 | 8 | 123 | 2 | EFO_0801724 | |
| Disease | systemic lupus erythematosus | COL6A3 HLA-DRB1 HLA-DRB5 KCP DGKQ ITGAM ELP3 HNRNPC VANGL2 ARHGAP4 TNXB | 5.28e-04 | 799 | 123 | 11 | MONDO_0007915 |
| Disease | Epstein Barr virus nuclear antigen 1 IgG measurement | 6.09e-04 | 9 | 123 | 2 | EFO_0007790 | |
| Disease | Ehlers-Danlos syndrome (is_implicated_in) | 6.09e-04 | 9 | 123 | 2 | DOID:13359 (is_implicated_in) | |
| Disease | gallbladder neoplasm | 6.09e-04 | 9 | 123 | 2 | EFO_0004606 | |
| Disease | complement factor B measurement | 6.09e-04 | 9 | 123 | 2 | EFO_0008096 | |
| Disease | central nervous system non-hodgkin lymphoma | 6.09e-04 | 9 | 123 | 2 | MONDO_0044887 | |
| Disease | HLA class II histocompatibility antigen, DQ alpha 2 chain measurement | 6.09e-04 | 9 | 123 | 2 | EFO_0801686 | |
| Disease | factor VIII measurement | 6.24e-04 | 40 | 123 | 3 | EFO_0004630 | |
| Disease | abdominal aortic aneurysm (is_marker_for) | 7.59e-04 | 10 | 123 | 2 | DOID:7693 (is_marker_for) | |
| Disease | ubiquitin-conjugating enzyme E2 G2 measurement | 7.59e-04 | 10 | 123 | 2 | EFO_0022035 | |
| Disease | CCL19 measurement | 7.59e-04 | 10 | 123 | 2 | EFO_0009415 | |
| Disease | cAMP-specific 3',5'-cyclic phosphodiesterase 4D measurement | 9.25e-04 | 11 | 123 | 2 | EFO_0020224 | |
| Disease | aspirin-induced respiratory disease (is_implicated_in) | 9.25e-04 | 11 | 123 | 2 | DOID:0080822 (is_implicated_in) | |
| Disease | Acute Promyelocytic Leukemia | 9.41e-04 | 46 | 123 | 3 | C0023487 | |
| Disease | Congenital muscular dystrophy | 1.11e-03 | 12 | 123 | 2 | cv:C0699743 | |
| Disease | anti-Epstein Barr virus antibody measurement | 1.11e-03 | 12 | 123 | 2 | EFO_0009273 | |
| Disease | Early Pregnancy Loss | 1.14e-03 | 109 | 123 | 4 | C3830362 | |
| Disease | Spontaneous abortion | 1.14e-03 | 109 | 123 | 4 | C0000786 | |
| Disease | Miscarriage | 1.14e-03 | 109 | 123 | 4 | C4552766 | |
| Disease | Abortion, Tubal | 1.14e-03 | 109 | 123 | 4 | C0000822 | |
| Disease | Schizophrenia | CHL1 ANK3 HLA-DRB1 LAMA2 ITGAM ABCB1 WDR11 KAT8 LRP1 EN1 TNXB | 1.19e-03 | 883 | 123 | 11 | C0036341 |
| Disease | Fetal Alcohol Spectrum Disorders | 1.30e-03 | 13 | 123 | 2 | C2985290 | |
| Disease | complement C4 measurement | 1.35e-03 | 52 | 123 | 3 | EFO_0004984 | |
| Disease | C-C motif chemokine 19 measurement | 1.52e-03 | 14 | 123 | 2 | EFO_0008047 | |
| Disease | GDH/6PGL endoplasmic bifunctional protein measurement | 1.52e-03 | 14 | 123 | 2 | EFO_0801619 | |
| Disease | Mammary Carcinoma, Human | 1.64e-03 | 525 | 123 | 8 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 1.64e-03 | 525 | 123 | 8 | C1257931 | |
| Disease | Mammary Neoplasms | 1.68e-03 | 527 | 123 | 8 | C1458155 | |
| Disease | Malignant neoplasm of breast | RAF1 FNDC3B XIRP1 KRT18 LAMA2 GRB7 ABCB6 H6PD ELP3 ABCB1 KMT2D NOS3 | 1.80e-03 | 1074 | 123 | 12 | C0006142 |
| Disease | Breast Carcinoma | 1.92e-03 | 538 | 123 | 8 | C0678222 | |
| Disease | neutrophil collagenase measurement | 1.99e-03 | 16 | 123 | 2 | EFO_0008248 | |
| Disease | endoplasmic reticulum resident protein 29 measurement | 1.99e-03 | 16 | 123 | 2 | EFO_0020346 | |
| Disease | Sjogren syndrome | 2.03e-03 | 60 | 123 | 3 | EFO_0000699 | |
| Disease | anti-anoctamin 2 antibody measurement | 2.25e-03 | 17 | 123 | 2 | EFO_0010150 | |
| Disease | response to radiation, Urinary retention | 2.25e-03 | 17 | 123 | 2 | GO_0009314, HP_0000016 | |
| Disease | muscular dystrophy (is_implicated_in) | 2.25e-03 | 17 | 123 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | response to interferon-beta, anti-drug antibody measurement | 2.25e-03 | 17 | 123 | 2 | EFO_0010559, GO_0035456 | |
| Disease | Alzheimer's disease (is_implicated_in) | 2.30e-03 | 132 | 123 | 4 | DOID:10652 (is_implicated_in) | |
| Disease | transient cerebral ischemia (implicated_via_orthology) | 2.45e-03 | 64 | 123 | 3 | DOID:224 (implicated_via_orthology) | |
| Disease | lupus nephritis (is_implicated_in) | 2.52e-03 | 18 | 123 | 2 | DOID:0080162 (is_implicated_in) | |
| Disease | late-onset myasthenia gravis | 2.52e-03 | 18 | 123 | 2 | EFO_1001490 | |
| Disease | Sjogren's syndrome (is_implicated_in) | 2.52e-03 | 18 | 123 | 2 | DOID:12894 (is_implicated_in) | |
| Disease | Colorectal Carcinoma | 2.76e-03 | 702 | 123 | 9 | C0009402 | |
| Disease | X-11470 measurement | 2.81e-03 | 19 | 123 | 2 | EFO_0021241 | |
| Disease | facial attractiveness measurement | 2.81e-03 | 19 | 123 | 2 | EFO_0009892 | |
| Disease | ulcerative colitis | 2.86e-03 | 335 | 123 | 6 | EFO_0000729 | |
| Disease | Benign Neoplasm | 2.91e-03 | 68 | 123 | 3 | C0086692 | |
| Disease | Neoplasms | 2.91e-03 | 68 | 123 | 3 | C0027651 | |
| Disease | apolipoprotein A 1 measurement | 2.96e-03 | 848 | 123 | 10 | EFO_0004614 | |
| Disease | corneal hysteresis | 3.12e-03 | 20 | 123 | 2 | EFO_0010066 | |
| Disease | end stage renal disease (implicated_via_orthology) | 3.12e-03 | 20 | 123 | 2 | DOID:783 (implicated_via_orthology) | |
| Disease | Lymphoma, Follicular | 3.12e-03 | 20 | 123 | 2 | C0024301 | |
| Disease | venous thromboembolism | 3.22e-03 | 460 | 123 | 7 | EFO_0004286 | |
| Disease | nephrotic syndrome | 3.29e-03 | 71 | 123 | 3 | EFO_0004255 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 3.29e-03 | 71 | 123 | 3 | DOID:0050700 (implicated_via_orthology) | |
| Disease | left atrial function | 3.44e-03 | 21 | 123 | 2 | EFO_0004294 | |
| Disease | Neutropenia | 3.44e-03 | 21 | 123 | 2 | C0027947 | |
| Disease | advanced glycosylation end product-specific receptor ligand measurement | 3.44e-03 | 21 | 123 | 2 | EFO_0010762 | |
| Disease | esophagus adenocarcinoma (is_implicated_in) | 3.44e-03 | 21 | 123 | 2 | DOID:4914 (is_implicated_in) | |
| Disease | Henoch-Schoenlein purpura | 3.77e-03 | 22 | 123 | 2 | EFO_1000965 | |
| Disease | N-glycan measurement | 3.77e-03 | 22 | 123 | 2 | EFO_0004999 | |
| Disease | Bipolar Disorder | 3.93e-03 | 477 | 123 | 7 | C0005586 | |
| Disease | asparaginase hypersensitivity | 4.13e-03 | 77 | 123 | 3 | EFO_0004881 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DARERSYQGVVQFAV | 206 | Q9ULK5 | |
| IYVINQAGDTIFNRA | 211 | P15291 | |
| GNYTVRVVAGNETQR | 111 | A8MTB9 | |
| NGRYSSNEFIVEVNV | 786 | Q9BQT9 | |
| EVSQRQAFQETRGYI | 311 | O43306 | |
| DGTRTNVYLNEVQVA | 71 | Q9H116 | |
| GTLTVEQIYQDRDQF | 116 | Q14254 | |
| YAFAGRQNNEITTIE | 56 | Q9BZP6 | |
| QDNRRFVSQETGNLY | 166 | Q8IWV2 | |
| QVSQTRFYVAESRDV | 481 | P52824 | |
| FNDTIADNIRYGRVT | 676 | Q9NP58 | |
| KVTTVDRFQGQQNDY | 1256 | O60306 | |
| NGQTVERTVAQYFRE | 301 | Q9H9G7 | |
| VSIVQVNSAGQREEY | 1786 | O14578 | |
| RSIQNNVREAVSGRY | 396 | Q14624 | |
| ISQGEADINIAFYQR | 151 | P22894 | |
| TIVQQFGYQRRASDD | 31 | P04049 | |
| QEQIRARDNISYGTN | 101 | Q8TBF8 | |
| QFSRLVYRAQVSENS | 241 | Q9Y5F3 | |
| YQRNRFGAQQDTIEV | 846 | P49736 | |
| ATTIAENIRYGRENV | 481 | P08183 | |
| VRFQGERIAYEVSVQ | 346 | O75106 | |
| RAQQGVQRQGVSYSV | 56 | Q8IVT2 | |
| VNGAVTYEINRRQSE | 286 | Q96JQ0 | |
| QTRAEGQRQAQEYEA | 351 | P05783 | |
| QYVNERNARAAVAGE | 56 | P07910 | |
| SDNYNIVRINRFNGT | 431 | Q9NZR2 | |
| NYGVGESFTVQRRVE | 111 | Q30154 | |
| RYQFRVIAVNEVGRS | 681 | O00533 | |
| NNVVFVTGNYVLDRD | 551 | Q7L2J0 | |
| AGRDIFAQRSQVTNY | 261 | P50440 | |
| TAQRISVFREGNAYT | 81 | A6NFK2 | |
| YTQASQNIRIVGAEV | 131 | P16233 | |
| AERVDQAYRENGFNI | 101 | Q86SR1 | |
| IQSRVNDQEGREEFY | 76 | Q9H7Z6 | |
| RVNRFNSTEYQVVTR | 441 | Q07954 | |
| VAQNEEGDAAYQRAR | 211 | Q86YB7 | |
| IERGEVNRRSANNFY | 276 | Q16206 | |
| VQTQQTGTVRFDGYV | 71 | Q9UK73 | |
| FRGTYCQQREVEAIT | 1616 | Q96RV3 | |
| CNERFSEDGYRTVVQ | 306 | Q14332 | |
| TVRFVHVYSNRQQEF | 416 | Q9Y2G8 | |
| SVRVSAVLYQERENG | 201 | O60928 | |
| QFASQQQVYRDIGEE | 66 | O43896 | |
| NGRFYQCEVVRLTTE | 911 | O75164 | |
| VRAVQQQLAYARATG | 1386 | P10070 | |
| TRGIFTVQVDENRRY | 2631 | P24043 | |
| IRVFDQYQRSTGQEL | 231 | O76027 | |
| IQNGAQGIRFIYTRE | 36 | P31943 | |
| QSGVVFAQRAFDYEQ | 506 | Q9Y5G0 | |
| VGRYFTINRDNGIVS | 506 | Q9UN70 | |
| EFQANRYITEQRRQT | 321 | Q05925 | |
| ADVNESNVYVVTQGR | 276 | Q14451 | |
| LYRDEVQNAQQRGVF | 1056 | P29474 | |
| QLFQYQEGVREEQRS | 691 | O94913 | |
| NGRVYFVNHNTRITQ | 451 | Q96J02 | |
| TEGQRRNVAVVNSLY | 571 | Q9UP83 | |
| TQRVRSGDVYVERVQ | 86 | Q93033 | |
| NVRNGTQVRYYREAE | 226 | P48547 | |
| VRVAVVQYSGTGQQR | 871 | P12109 | |
| DRARQYVLQSDGVQQ | 361 | Q5T2R2 | |
| QISGLQTNTDYRFRV | 1111 | Q53EP0 | |
| QAFQATARANVYVTE | 216 | O43909 | |
| QVSTTERVFQDRQYQ | 681 | Q13619 | |
| GQDRVRVAVVQYSDR | 1061 | P12111 | |
| RGARVAVVTYNNEVT | 2441 | P12111 | |
| FTVRDNRDNTAGVYA | 541 | P55287 | |
| NYGVVESFTVQRRVQ | 111 | P01911 | |
| QETRGTFYTTRQQKQ | 3126 | Q12955 | |
| NVGKTVFEYRTQNVA | 1456 | P05997 | |
| NYGVVESFTVQRRVQ | 111 | P13762 | |
| GVQSVYEDVARDTNR | 246 | Q9H9T3 | |
| NLVNNGYVRDETVRA | 151 | P04180 | |
| QRQVVAGLNFRITYS | 186 | P01042 | |
| RQVFAVQRIFENGYD | 96 | P08246 | |
| QGIREEEVSYQLAFN | 791 | Q9NV70 | |
| GQYQSYSEQVRRELQ | 311 | O95479 | |
| YSVTGIDQVSFRGQR | 256 | O14815 | |
| RQQFYVQVSGTEYEV | 591 | Q8IWY4 | |
| YSGVAAQVEVFRRQD | 956 | O00411 | |
| ESEQARQRRVQSYEF | 181 | Q9NVU0 | |
| ERGEVNRRSANQFYS | 291 | Q8TC92 | |
| ASTTERVFQDRQYQI | 836 | Q13620 | |
| ATDAQAVDRVYRIGQ | 561 | Q2NKX8 | |
| EVRSGYRIQASQQDD | 386 | Q86X29 | |
| IRVDGNDVFAVYNAT | 296 | P12694 | |
| VTAFYRGRQVFQQTI | 206 | Q14653 | |
| RRQVTRGYTQENQDT | 311 | O00635 | |
| NQYAVSGEIFVVDRN | 926 | Q02880 | |
| GVRLDTARQETNYVE | 661 | Q9BRC7 | |
| FVNELRYGVARSDQV | 116 | P53816 | |
| YDGNRVTNFVAQRLS | 71 | Q15750 | |
| GHQYQSQETFRLQER | 376 | Q6ZWJ8 | |
| NTTGYNDRAVLEREV | 246 | P49354 | |
| RAEVGDTIQVVFYNR | 461 | Q9BQS7 | |
| ETVDSVLRNRGVYEN | 436 | Q96CC6 | |
| QVFEETQIGGERYNF | 346 | Q99832 | |
| VVNYFRTVGFEEQAS | 56 | Q5VXD3 | |
| NTRRTQADNIFIYES | 61 | Q8N8Z3 | |
| VRNDGEDSYRTQVTF | 806 | P11215 | |
| TSIANQAVRIQEGRY | 291 | Q96JY6 | |
| AGRRRGQQQETETFY | 426 | P98171 | |
| ERQVGRQSAFQYLQS | 1121 | O75339 | |
| HTYERVLQQQGSQER | 51 | Q96A22 | |
| EGTINFIVNETNRYA | 151 | Q6P3X8 | |
| QIFVDYGRVNTAAVN | 231 | Q92959 | |
| SRQRFRQFCYQEVTG | 36 | Q9NX65 | |
| FQQSVQEYRRSAQDG | 456 | Q9BQ52 | |
| RSNIFSREEVTGYQR | 296 | P51449 | |
| GNYFDNDRNRRIQVE | 81 | Q7RTT4 | |
| RVDIARSQIFIYGQQ | 491 | Q9HCF6 | |
| EVDRFVVSYVSAGNQ | 866 | P22105 | |
| VDRNINYTERGVFFS | 316 | P80108 | |
| EYNEGTSSVQNRVRF | 421 | Q8IZM8 | |
| ETNGGQVTYRVVQVT | 71 | Q15853 | |
| QRQNRYDGQVAVFGS | 446 | P22314 | |
| QRTFVSTLQRYQEEG | 981 | Q8IUG5 | |
| YRDTEDREAFQTGQN | 181 | Q8NEK5 | |
| YVGFTVNTARRVQQH | 31 | Q9BQ83 | |
| GSVEDQRRQQGYFVR | 186 | Q00G26 | |
| VRRSYNNIFTTSNEE | 316 | Q9BZH6 | |
| RTVTEQYEEVDQFGN | 1766 | Q702N8 | |
| DTQSYVLNFRGRVTQ | 371 | O75386 | |
| QYRDIRRTQNADGFS | 36 | Q8N2U9 | |
| VQTIRNVFSVEAGYR | 41 | O95922 | |
| GEIEQGSNRRYQVSA | 871 | Q5TIE3 | |
| TFAQGVINEADQRQY | 3496 | O14686 | |
| VYTSYNTVQNDRRGV | 606 | P29120 |